Skip to Main Content
Our Commitment to Diversity

2021 Hot Topics in the 340B Drug Pricing Program

KL Gates Hosted Event
Date: 19 October 2021

Over the past year, there has been an unprecedented level of regulatory, legal, and policy developments impacting the 340B Drug Pricing Program. In this webinar, our lawyers discuss some of these developments, including 340B reimbursement under the Hospital Outpatient Prospective Payment System, contract pharmacy actions by drug manufacturers and related litigation, the status of state laws prohibiting 340B two-tier pricing models and other actions by pharmacy benefit managers, and recent federal legislative action impacting 340B stakeholders.

  • Tom Mirga, Editor in Chief, 340B Report
Return to top of page

Email Disclaimer

We welcome your email, but please understand that if you are not already a client of K&L Gates LLP, we cannot represent you until we confirm that doing so would not create a conflict of interest and is otherwise consistent with the policies of our firm. Accordingly, please do not include any confidential information until we verify that the firm is in a position to represent you and our engagement is confirmed in a letter. Prior to that time, there is no assurance that information you send us will be maintained as confidential. Thank you for your consideration.

Accept Cancel